How much funding has Halda Therapeutics raised?

Halda Therapeutics has raised $202.0M in total funding, most recently a Series B round.

Who are Halda Therapeutics's investors?

Halda Therapeutics's investors include Johnson & Johnson Innovation, RA Capital Management, Canaan Partners, Deep Track Capital, Frazier Life Sciences, Vida Ventures.

When was Halda Therapeutics founded?

Halda Therapeutics was founded in 2019.

Where is Halda Therapeutics headquartered?

Halda Therapeutics is headquartered in New Haven, Connecticut, United States.

What industry is Halda Therapeutics in?

Halda Therapeutics operates in Biotech, Healthcare.

How many employees does Halda Therapeutics have?

Halda Therapeutics has 1-10 employees.

Halda Therapeutics

Acquired

Taking Hold. Conquering Cancer.

New Haven, United States · Founded 2019 · $202.0M raised

Biotech

Healthcare

Headquarters: New Haven, Connecticut
Employees: 1–10
Founded: 2019
Business Model: B2B

Website: haldatx.com
Total Funding: $202.0M
Last Round: $126.0M Series BAug 2024
Rounds: 2

About

Halda Therapeutics, founded in 2019 by Yale professor Craig Crews, is a clinical-stage biotech developing RIPTAC therapeutics for cancer. Acquired by J&J for ~$3B in 2025.

Summary

Halda Therapeutics is a Biotech company based in New Haven, United States, founded in 2019. It has raised $202.0M in total across 2 rounds, most recently a $126.0M Series B round in Aug 2024. Investors include Johnson & Johnson Innovation, RA Capital Management and Canaan Partners.

LinkedIn X (Twitter)